Davidson & Garrard’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Davidson & Garrard's ABBV Position: Q3 2017 in Review
Davidson & Garrard reduced its AbbVie (ABBV) stake by 0.85% in Q3 2017, selling an estimated $73.5K and leaving 113,099 shares worth $10.1M. The position accounts for 2.37% of the portfolio, ranked #3.
Davidson & Garrard first reported a position in ABBV in Q2 2013 and has held it in 18 quarters since. 1,797 funds tracked by Wall St. Rank hold ABBV as of Q3 2017.
- Davidson & Garrard held 113,099 shares of AbbVie worth $10.1M as of Q3 2017.
- Davidson & Garrard sold 966 AbbVie shares in Q3 2017, an estimated $73.5K.
- AbbVie made up 2.37% of Davidson & Garrard's portfolio in Q3 2017, its #3 holding.
- Davidson & Garrard first reported a position in AbbVie in Q2 2013 and has held it in 18 quarters since.
- 1,797 funds tracked by Wall St. Rank held AbbVie as of Q3 2017.
Based on Davidson & Garrard's 13F filing for Q3 2017, filed 7 Nov 2017.